Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension
Journal of Scleroderma and Related Disorders · 2025-10 · 10 (3) · 443-451
DOI: 10.1177/23971983241296721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Scleroderma and Related Disorders, online erschienen am 27.11.2024. Verfasst von Samuel H Friedman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Advances in pulmonary arterial hypertension therapies have led to improvements in the quality of life and survival for patients with idiopathic pulmonary arterial hypertension, but these trends have not uniformly translated to patients with systemic sclerosis–associated pulmonary arterial hypertension. In order to better understand the heterogeneity in treatment response and survival, we aimed to examine the histological and immunophenotypic differences between the systemic sclerosis–associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension pulmonary vasculopathies. We performed a semi-quantitative lung morphometry–based analysis comparing sections obtained from systemic sclerosis–associated pulmonary arterial hypertension (n = 24), idiopathic pulmonary arterial hypertension (n = 9), and control (n = 13) bio-banked lung tissue specimens. H&E (Hematoxylin and Eosin) and VVG (Verhoeff-Van Gieson)-stained lung sections were analyzed for interstitial and vascular pathology. Immunohistochemistry was used to stain for an array of inflammatory and fibrosis mediators. Baseline demographic and hemodynamic data for each patient were collected via chart review at the time of lung explantation. Plexiform lesions were present in 5/9 (55%) of idiopathic pulmonary arterial hypertension samples, but absent in all systemic sclerosis–associated pulmonary arterial hypertension samples (0/24). Systemic sclerosis–associated pulmonary arterial hypertension lungs demonstrated significantly worse interstitial fibrosis (p = 0.0001) and interstitial cellularity (p = 0.0002) compared to idiopathic pulmonary arterial hypertension lungs. The degree of smooth muscle hypertrophy and pulmonary artery intimal proliferation were not different between systemic sclerosis–associated pulmonary arterial hypertension and idiopathic pulmonary arterial hypertension lungs. Immunohistochemistry analysis revealed that systemic sclerosis–associated pulmonary arterial hypertension lungs exhibited increased interstitial infiltration of CD3 T-cells (p = 0.009), CD20 B-cells (p = 0.01), and CD163 macrophages (p = 0.048) when compared to idiopathic pulmonary arterial hypertension and control lungs. Systemic sclerosis–associated pulmonary arterial hypertension lungs display a distinct pulmonary vascular pathology as well as significant interstitial fibrosis when compared to idiopathic pulmonary arterial hypertension lungs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
- Department of Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
- Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
ORCID-Profile: Samuel H Friedman, Richard M Silver
Förderung
- NIAMS NIH HHS
- NHLBI NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Division of Intramural Research
Zitieren
APA
Friedman, S. H., Harley, R. A., Williams, J., Forcucci, J. A., Ramakrishnan, V., Strange, C., Silver, R. M., Feghali-Bostwick, C., & Argula, R. G. (2025). Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension. Journal of Scleroderma and Related Disorders, 10(3), 443-451. https://doi.org/10.1177/23971983241296721
Vancouver
Friedman SH, Harley RA, Williams J, Forcucci JA, Ramakrishnan V, Strange C, et al. Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension. Journal of Scleroderma and Related Disorders. 2025;10(3):443-451. doi:10.1177/23971983241296721
BibTeX
@article{Friedman2025,
author = {Friedman, Samuel H and Harley, Russell A and Williams, Jacob and Forcucci, Jessica A and Ramakrishnan, Viswanathan and Strange, Charlie and Silver, Richard M and Feghali-Bostwick, Carol and Argula, Rahul G},
title = {Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension},
journal = {Journal of Scleroderma and Related Disorders},
year = {2025},
volume = {10},
number = {3},
pages = {443--451},
doi = {10.1177/23971983241296721}
}
EUVIMED